These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18207603)

  • 1. Effect of deregulation on the prices of nicotine replacement therapy products in Finland.
    Aalto-Setälä V; Alaranta A
    Health Policy; 2008 May; 86(2-3):355-62. PubMed ID: 18207603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine replacement therapy practices in Finland one year after deregulation of the product sales--has anything changed from the community pharmacy perspective?
    Kurko T; Linden K; Vasama M; Pietilä K; Airaksinen M
    Health Policy; 2009 Aug; 91(3):277-85. PubMed ID: 19195735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and acquisition of nicotine replacement therapy products among underaged adolescents after deregulation of the sales.
    Rainio SU; Huhtala HS; Rimpelä AH
    Nicotine Tob Res; 2010 Aug; 12(8):870-3. PubMed ID: 20622024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discontinuation of nicotine replacement therapy among smoking-cessation attempters.
    Burns EK; Levinson AH
    Am J Prev Med; 2008 Mar; 34(3):212-5. PubMed ID: 18312809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pricing behaviour of pharmacies after market deregulation for OTC drugs: the case of Germany.
    Stargardt T; Schreyögg J; Busse R
    Health Policy; 2007 Nov; 84(1):30-8. PubMed ID: 17553587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Access of over-the-counter nicotine replacement therapy products to minors.
    Johnson KC; Klesges LM; Somes GW; Coday MC; DeBon M
    Arch Pediatr Adolesc Med; 2004 Mar; 158(3):212-6. PubMed ID: 14993077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of advertising on nicotine replacement therapy demand.
    Tauras JA; Chaloupka FJ; Emery S
    Soc Sci Med; 2005 May; 60(10):2351-8. PubMed ID: 15748682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with varenicline and nicotine replacement therapy.
    Ebbert JO; Burke MV; Hays JT; Hurt RD
    Nicotine Tob Res; 2009 May; 11(5):572-6. PubMed ID: 19351781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery.
    Paciullo CA; Short MR; Steinke DT; Jennings HR
    Ann Pharmacother; 2009 Jul; 43(7):1197-202. PubMed ID: 19567657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The demand for nicotine replacement therapies.
    Tauras JA; Chaloupka FJ
    Nicotine Tob Res; 2003 Apr; 5(2):237-43. PubMed ID: 12745497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach.
    Medioni J; Berlin I; Mallet A
    Addiction; 2005 Feb; 100(2):247-54. PubMed ID: 15679754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of barriers that impede the implementation of nicotine replacement therapy in the acute cardiac care setting.
    May FC; Stocks N; Barton C
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):646-50. PubMed ID: 18779735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescents' self-reported reasons for using nicotine replacement therapy products: a population-based study.
    Raisamo SU; Doku DT; Rimpelä AH
    Addict Behav; 2011 Sep; 36(9):945-7. PubMed ID: 21636216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is pharmaceutical policy evidence-informed? A case of the deregulation process of nicotine replacement therapy products in Finland.
    Kurko T; Silvast A; Wahlroos H; Pietilä K; Airaksinen M
    Health Policy; 2012 May; 105(2-3):246-55. PubMed ID: 22417863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family support and employment as predictors of smoking cessation success: a randomized, double-blind, placebo-controlled trial of nicotine sublingual tablets in chinese smokers.
    Sun HQ; Guo S; Chen DF; Jiang ZN; Liu Y; Di XL; Yang FD; Zhang XY; Kosten TR; Lu L
    Am J Drug Alcohol Abuse; 2009; 35(3):183-8. PubMed ID: 19462302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do e-cigarette sales reduce the demand for nicotine replacement therapy (NRT) products in the US? Evidence from the retail sales data.
    Huang J; Wang Y; Duan Z; Kim Y; Emery SL; Chaloupka FJ
    Prev Med; 2021 Apr; 145():106376. PubMed ID: 33346035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do pharmacy staff recommend evidenced-based smoking cessation products? A pseudo patron study.
    Chiang PP; Chapman S
    J Clin Pharm Ther; 2006 Jun; 31(3):205-9. PubMed ID: 16789985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do increases in cigarette prices lead to increases in sales of cigarettes with high tar and nicotine yields?
    Farrelly MC; Loomis BR; Mann NH
    Nicotine Tob Res; 2007 Oct; 9(10):1015-20. PubMed ID: 17852768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.